Based on share price movements since the election, the market still isn't anticipating the giant stimulus from a repatriation tax break.
Goldman says the strategy of buying the stocks most owned by hedge funds in terms of concentration has outperformed the market since 2001.
"FMHR" traders Josh Brown, Jim Lebenthal, Jon Najarian and LOOP Capital President Kourtney Gibson discuss value trade picks.
Cramer said that Pfizer is setting itself up to split with the creation of its Pfizer Innovative Health and Pfizer Essential Health.
Third Point believes there's a legitimate parallel between investing in the current tumult and the plot intrigue surrounding the HBO program.
The billion-dollar boom in movie production within Georgia is part of a big economic rebound story.
Jim Cramer shares his take on caller favorite stocks at rapid speed, including this popular asset manager.
Check out the companies making headlines after the bell Tuesday: Chipotle Mexican Grill, Oracle, Pure Storage and more.
CNBC "Halftime Report" trader Pete Najarian bought shares of General Motors Thursday for his model portfolio.
Activist investor Daniel Loeb has called for Dow Chemical to remove chief executive Andrew Liveris, according to The Wall Street Journal.
Jana Partner's Barry Rosenstein gave his latest thoughts on the market and explanations of his latest moves in a letter to clients this week.
Hedge fund Jana Partners took a long position in Microsoft, citing potential to improve operating margins and its cloud business.
Hedge fund manager Dan Loeb gave the investment rationales for two stocks and commentary on the market in a investor letter to clients.
Pete Najarian scooped up shares of JetBlue and Under Armour for his Halftime Report Portfolio on Tuesday, following a recent drop in both names.
Expectations are low that the Fed will provide any new policy insight next week, and focus should stay on economic reports and a flood of earnings.
The 10 largest U.S. hedge funds moved out of China amid recession fears and snapped up more healthcare and pharmaceutical stocks than any other industry in Q2.
Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid.
The “Mad Money” host Jim Cramer gives his take on Apple’s recent decline.
Jim Cramer reminds investors that breaking up is not always hard to do. It's easy to unlock value!
Check out the companies making headlines after the bell Wednesday: Family Dollar, Energizer & more.